tirzepatide and pancreas Possible pro-oncogenic effect of (TRZD) on the pancreas, Major physiological roles of GLP-1

30-A, Jalan 17/155C, Bandar Bukit Jalil, 57000 Kuala Lumpur, Malaysia Country of Origin: Malaysia Batch Number: PT260638 Manufacturing Date: 05/2026 Expiry Date: 05/2029 Disclaimer FOR RESEARCH PURPOSES ONLY

However, there are ways to address these issues with body contouring procedures

Label expansion: as the label for these GLP1s+ expand, it will naturally extend to already covered disease states (e.g., cardiovascular disease (CVD) for Medicare)

Retrieved from International Academy of Compounding Pharmacists

Some patients extend this timeline to 20 or 24 weeks by increasing doses every six to eight weeks instead of every four weeks

Ultimate management may be a hysterectomy and removal of the ovaries with subsequent replacement of hormones until the age of the menopause